IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ASHLEY NICOLE HOWARD

Allopathic & Osteopathic Physicians Family Medicine

NPI
1841649662
CMS profile
2331954
Location
CANTON, IL

General Payments · PY2021–2024

$2,257.57

  • Reported across 125 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$881.71

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family Medicine IL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $881.71 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $247.68 19
Almatica Pharma Inc. $142.52 7
Boehringer Ingelheim Pharmaceuticals, Inc. $125.39 6
Otsuka America Pharmaceutical, Inc. $101.19 5
E.R. Squibb & Sons, L.L.C. $96.16 5
Abbott Laboratories $52.55 3
Xeris Pharmaceuticals, Inc. $45.24 2
Acerta Pharma LLC $43.23 3
Exact Sciences Corporation $27.75 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $45.12 2
PY2022 $273.67 16
PY2023 $1,057.07 56
PY2024 $881.71 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $17.63 03/10/2024 Food and Beverage Undisputed 01/23/2026 1125300885 CMS
Abbott Laboratories $14.48 08/22/2024 Food and Beverage Undisputed 01/23/2026 1125300887 CMS
Abbott Laboratories $20.44 12/31/2024 Food and Beverage Undisputed 01/23/2026 1125300889 CMS
Almatica Pharma LLC $22.51 02/01/2024 Food and Beverage Undisputed 01/23/2026 1137565986 CMS
Almatica Pharma LLC $22.95 06/27/2024 Food and Beverage Undisputed 01/23/2026 1137565991 CMS
Almatica Pharma LLC $1.80 06/27/2024 Food and Beverage Undisputed 01/23/2026 1137565995 CMS
Almatica Pharma LLC $20.43 08/08/2024 Food and Beverage Undisputed 01/23/2026 1137565999 CMS
Almatica Pharma LLC $26.95 09/11/2024 Food and Beverage Undisputed 01/23/2026 1137566004 CMS
Almatica Pharma LLC $24.87 10/09/2024 Food and Beverage Undisputed 01/23/2026 1137566008 CMS
Almatica Pharma LLC $23.01 11/06/2024 Food and Beverage Undisputed 01/23/2026 1137566013 CMS
AstraZeneca Pharmaceuticals LP $13.42 01/22/2024 Food and Beverage Undisputed 01/23/2026 1104499630 CMS
AstraZeneca Pharmaceuticals LP $14.66 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105434904 CMS
AstraZeneca Pharmaceuticals LP $15.15 10/10/2024 Food and Beverage Undisputed 01/23/2026 1104269773 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.39 01/10/2024 Food and Beverage Undisputed 01/23/2026 1118180273 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.68 02/15/2024 Food and Beverage Undisputed 01/23/2026 1118180281 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.13 03/20/2024 Food and Beverage Undisputed 01/23/2026 1118180265 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.74 08/21/2024 Food and Beverage Undisputed 01/23/2026 1118180269 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.17 09/26/2024 Food and Beverage Undisputed 01/23/2026 1118180277 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.28 11/21/2024 Food and Beverage Undisputed 01/23/2026 1118180261 CMS
E.R. Squibb & Sons, L.L.C. $16.73 02/22/2024 Food and Beverage Undisputed 01/23/2026 1101736099 CMS
E.R. Squibb & Sons, L.L.C. $22.68 06/13/2024 Food and Beverage Undisputed 01/23/2026 1101736136 CMS
E.R. Squibb & Sons, L.L.C. $16.18 09/18/2024 Food and Beverage Undisputed 01/23/2026 1101736199 CMS
E.R. Squibb & Sons, L.L.C. $24.55 11/13/2024 Food and Beverage Undisputed 01/23/2026 1101736214 CMS
E.R. Squibb & Sons, L.L.C. $16.02 12/11/2024 Food and Beverage Undisputed 01/23/2026 1101736228 CMS
Exact Sciences Corporation $27.75 08/22/2024 Food and Beverage Undisputed 01/23/2026 1114538095 CMS
Novartis Pharmaceuticals Corporation $4.28 01/04/2024 Food and Beverage Undisputed 01/23/2026 1086811961 CMS
Novartis Pharmaceuticals Corporation $20.38 01/04/2024 Food and Beverage Undisputed 01/23/2026 1086811963 CMS
Novartis Pharmaceuticals Corporation $22.89 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086811951 CMS
Novartis Pharmaceuticals Corporation $3.00 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086811953 CMS
Novartis Pharmaceuticals Corporation $27.70 02/07/2024 Food and Beverage Undisputed 01/23/2026 1086811955 CMS
Novartis Pharmaceuticals Corporation $9.48 02/28/2024 Food and Beverage Undisputed 01/23/2026 1086811957 CMS
Novartis Pharmaceuticals Corporation $28.38 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086811959 CMS
Novartis Pharmaceuticals Corporation $21.43 07/11/2024 Food and Beverage Undisputed 01/23/2026 1086811967 CMS
Novartis Pharmaceuticals Corporation $2.83 07/11/2024 Food and Beverage Undisputed 01/23/2026 1086811969 CMS
Novartis Pharmaceuticals Corporation $3.62 08/01/2024 Food and Beverage Undisputed 01/23/2026 1086811973 CMS
Novartis Pharmaceuticals Corporation $20.02 08/01/2024 Food and Beverage Undisputed 01/23/2026 1086811975 CMS
Novartis Pharmaceuticals Corporation $6.78 09/05/2024 Food and Beverage Undisputed 01/23/2026 1086811977 CMS
Novartis Pharmaceuticals Corporation $16.35 09/05/2024 Food and Beverage Undisputed 01/23/2026 1086811979 CMS
Novartis Pharmaceuticals Corporation $14.31 09/19/2024 Food and Beverage Undisputed 01/23/2026 1086811985 CMS
Novartis Pharmaceuticals Corporation $1.14 09/19/2024 Food and Beverage Undisputed 01/23/2026 1086811987 CMS
Novartis Pharmaceuticals Corporation $8.85 10/11/2024 Food and Beverage Undisputed 01/23/2026 1086811983 CMS
Novartis Pharmaceuticals Corporation $8.68 10/31/2024 Food and Beverage Undisputed 01/23/2026 1086811991 CMS
Novartis Pharmaceuticals Corporation $4.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 1086811993 CMS
Novartis Pharmaceuticals Corporation $23.56 12/05/2024 Food and Beverage Undisputed 01/23/2026 1086811995 CMS
Otsuka America Pharmaceutical, Inc. $28.00 02/21/2024 Food and Beverage Undisputed 01/23/2026 1118910377 CMS
Otsuka America Pharmaceutical, Inc. $15.78 03/27/2024 Food and Beverage Undisputed 01/23/2026 1118910379 CMS
Otsuka America Pharmaceutical, Inc. $17.06 06/26/2024 Food and Beverage Undisputed 01/23/2026 1118910381 CMS
Otsuka America Pharmaceutical, Inc. $22.46 10/02/2024 Food and Beverage Undisputed 01/23/2026 1118910383 CMS
Otsuka America Pharmaceutical, Inc. $17.89 11/27/2024 Food and Beverage Undisputed 01/23/2026 1118910385 CMS
Xeris Pharmaceuticals, Inc. $21.17 01/11/2024 Food and Beverage Undisputed 01/23/2026 1144587822 CMS
Xeris Pharmaceuticals, Inc. $24.07 02/29/2024 Food and Beverage Undisputed 01/23/2026 1144587820 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.